This year, I want to focus on investing in both TSLA and HIMS, aiming for an annual return of over 100%.
The reason for investing in TSLA is that there are still many ignorant people who only think of it as an EV company. Elon Musk said in last year's Q1 earnings that he would focus on investing in production facilities rather than vehicle production this year. If a budget version model produced by those facilities is released, the customer deliveries will likely change significantly. Moreover, the highly anticipated robotaxi, which is on the verge of practical use, may even operate within this year. If it reaches that point, surpassing $1000 by the end of the year seems feasible.
The reason for investing in HIMS is similar to the customer deliveries for TSLA, as the stock price drops by about 10% just by the possibility of competition supplying weight loss drugs, which represent less than 10% of its revenue. Furthermore, the offered price is 20% cheaper than the competition's, and no stockouts have occurred. The company's growth rate is also remarkable, maintaining a 70% pace in revenue since its founding 7 years ago. The current revenue has reached half of PLTR's, yet for some reason, its Market Cap is cheap compared to PLTR, at only 1/30th.
Having said that, I also buy NU and NFLX.
The reason for investing in TSLA is that there are still many ignorant people who only think of it as an EV company. Elon Musk said in last year's Q1 earnings that he would focus on investing in production facilities rather than vehicle production this year. If a budget version model produced by those facilities is released, the customer deliveries will likely change significantly. Moreover, the highly anticipated robotaxi, which is on the verge of practical use, may even operate within this year. If it reaches that point, surpassing $1000 by the end of the year seems feasible.
The reason for investing in HIMS is similar to the customer deliveries for TSLA, as the stock price drops by about 10% just by the possibility of competition supplying weight loss drugs, which represent less than 10% of its revenue. Furthermore, the offered price is 20% cheaper than the competition's, and no stockouts have occurred. The company's growth rate is also remarkable, maintaining a 70% pace in revenue since its founding 7 years ago. The current revenue has reached half of PLTR's, yet for some reason, its Market Cap is cheap compared to PLTR, at only 1/30th.
Having said that, I also buy NU and NFLX.
Translated
17
1
Translated
$Churchill Downs (CHDN.US)$
Horse racing losses can be recovered here
Horse racing losses can be recovered here
Translated
Wow.
Translated
![Picture](https://sgsnsimg.moomoo.com/feed_image/182802703/e5550862ea1d31ddb8dda91dd716e1c7.jpg/thumb)
4
Whoa whoa
Translated